Biomarker Effects Were Present Despite clinical failure, semaglutide showed biological activity: CSF biomarkers including pTau181, pTau217, and others demonstrated nominally significant reductions of approximately 10% in treated patients
Many users report 50-70% improvement in symptoms by week 4
A more likely explanation, he says, is telogen effluvium, a temporary shedding condition triggered by stress
Because IGF-I exerts anti-inflammatory actions and is important for peripheral glucose uptake, metabolic disturbances in these patients can, in part, be explained by the low IGF-I levels (83)
Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM
Similar findings were observed using 15 N 13 C-cystine and by performing high-resolution proteomics (Fig